Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Abroad (travel likely)RecruitingPHASE1

Conditions

Malignant Female Reproductive System Neoplasm · Recurrent Cervical Carcinoma · Recurrent Endometrial Carcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma · Recurrent Vaginal Carcinoma · Stage IV Cervical Cancer AJCC v8 · Stage IV Fallopian Tube Cancer AJCC v8 · Stage IV Ovarian Cancer AJCC v8 · Stage IV Primary Peritoneal Cancer AJCC v8 · Stage IV Uterine Corpus Cancer AJCC v8 · Stage IV Vaginal Cancer AJCC v8 · Stage IVA Cervical Cancer AJCC v8 · Stage IVA Fallopian Tube Cancer AJCC v8 · Stage IVA Ovarian Cancer AJCC v8 · Stage IVA Primary Peritoneal Cancer AJCC v8 · Stage IVA Uterine Corpus Cancer AJCC v8 · Stage IVA Vaginal Cancer AJCC v8 · Stage IVB Cervical Cancer AJCC v8 · Stage IVB Fallopian Tube Cancer AJCC v8 · Stage IVB Ovarian Cancer AJCC v8 · Stage IVB Primary Peritoneal Cancer AJCC v8 · Stage IVB Uterine Corpus Cancer AJCC v8 · Stage IVB Vaginal Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Jessica Leitzel) · Jvogel10@jhmi.edu · 410-502-9242
    Contact: Principal Investigator (Stéphanie Gaillard, MD PhD)
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Lilie L. Lin) · lllin@mdanderson.org · 713-563-2300
    Contact: Principal Investigator (Lilie L. Lin)
Study leads
  • Lilie L Lin

    Principal Investigator

    M.D. Anderson Cancer Center